Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: Cohort and case-control study

Vaccine

Volumn 30, Issue 2, 2012, Pages 195-200

  Castilla, Jesús ^a,b   Martínez Artola, Víctor ^c   Salcedo, Esther ^c   Martínez Baz, Iván ^a,b   García Cenoz, Manuel ^a,b   Guevara, Marcela ^a,b   Álvarez, Nerea ^d   Irisarri, Fátima ^a,b   Morán, Julio ^d   Barricarte, Aurelio ^a,b  

^a INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c Universidad Pública de Navarra   (Spain)

^d Unidad de Patología Crónica Compleja Servicio de Pediatría y Áreas Específicas Hospital Universitario de Navarra Servicio Navarro de Salud Osasunbidea   (Spain)

Author keywords

Case control studies; Cohort studies; H1N1 subtype; Influenza A virus; Influenza vaccines; Spain

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; COMORBIDITY; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA B; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEASONAL INFLUENZA; SPAIN;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; RISK FACTORS; SPAIN;

EID: 84355162726     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.11.024     Document Type: Article

References (23)

1. Glezen W.P. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982, 4:25-44.
2. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Bridges C.B., Cox N.J., et al. Influenza-associated hospitalizations in the United States. JAMA 2004, 292:1333-1340.
3. Orenstein W.A., Bernier R.H., Hinman A.R. Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev 1988, 10:212-240.
4. Valenciano M., Kissling E., Ciancio B.C., Moren A. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioners networks. Vaccine 2010, 28:7381-7388.
5. Jackson L.A., Jackson M.L., Nelson J.C., Neuzil K.M., Weiss N.S. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006, 35:337-344.
6. Jefferson T., Rivetti A., Rudin M., Pietrantonj, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005, 366:1165-1174.
7. Groenwold R.H., Hoes A.W., Nichol K.L., Hak E. Quantifying the potential role of unmeasured confounders: the example of influenza vaccination. Int J Epidemiol 2008, 37:1422-1429.
8. Puig-Barberà J., Arnedo-Pena A., Pardo-Serrano F., Tirado-Balaguer M.D., Pérez-Vilar S., Silvestre-Silvestre E., et al. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study. Vaccine 2010, 28:7460-7467.
9. Valenciano M., Kissling E., Cohen J.M., Oroszi B., Barret A.S., Rizzo C., et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of influenza monitoring vaccine effectiveness in Europe (I-MOVE) multicentre case-control study. PLoS Med 2011, 8(1):e1000388.
10. Skowronski D.M., Janjua N.Z., De Serres G., Hottes T.S., Dickinson J.A., Crowcroft N., et al. Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. BMJ 2011, 342:7297.
11. Wu J., Xu F., Lu L., Lu M., Miao L., Gao T., et al. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. N Engl J Med 2010, 363:2416-2423.
12. Orenstein E.W., De Serres G., Haber M.J., Brodges C.B., Gargiullo P., Orestein W.A. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007, 36:623-631.
13. Halloran M.E., Longini I.M. Using validation sets for outcomes and exposure to infection in vaccine field studies. Am J Epidemiol 2001, 154:391-398.
14. European Centre for Disease Prevention and Control. ECDC risk assessment: Seasonal influenza 2010-2011 in Europe (EU/EEA countries). Stockholm: ECDC; January 2011. Available from: http://www.ecdc.europa.eu/en/publications/Publications/110125_RA_Seasonal_Influenza_EU-EEA_2010-2011.pdf.
15. Recommended virus for influenza vaccines for use in the 2010-2011 northern hemisphere influenza. Wkly Epidemiol Rec 2010, 85:81-92.
16. World Health Organization. Availability of a candidate reassortant vaccine virus for the novel influenza A (H1N1) vaccine development. Geneva: WHO; 4 June 2009. Available from: http://www.who.int/csr/resources/publications/swineflu/ivr153_20090608_en.pdf.
17. Instituto de Salud Pública de Navarra. Protocolo de vacunación antigripal 2010-2011. Boletín Informativo n° 59; Septiembre 2010. http://www.navarra.es/NR/rdonlyres/C1F0BC1C-B6F7-4706-9DF8-71A2064C7774/165169/BOL59INTCampanaGripe.pdf.
18. Pebody R., Hardelid P., Fleming D.M., McMenamin J., Andrews N., Robertson C., et al. Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Euro Surveill 2011, 16(6). pii=19791.
19. Kissling E., Valenciano M. I-MOVE case-control studies team. Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study. Euro Surveill 2011, 16(11). pii=19818.
20. Puig-Barbera J., Diez-Domingo J., Perez-Hoyos S., Belenguer Varea A., González Vidal E. Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age. Vaccine 2004, 23:283-289.
21. Naghavi M., Barlas Z., Siadaty S., Naguib S., Madjid M., Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000, 102:3039-3045.
22. Lavallée P., Pechaud V., Gautier-Bertrand M., Grabli D., Marenco P. Association between influenza vaccination and reduced risk of brain infarction. Stroke 2002, 33:513-518.
23. Gurfinkel E.P., Leon de la Fuente R., Mendiz O., Mautner B. Flu vaccination in acute coronary interventions (FLUVACS) Study. One-year follow-up. Eur Heart J 2004, 25:25-31.